{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T15:10:54Z","timestamp":1701184254942},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T00:00:00Z","timestamp":1397260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s40256-014-0074-3","type":"journal-article","created":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T20:27:54Z","timestamp":1397248074000},"page":"313-318","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Severe Left Ventricular Systolic Dysfunction is Independently Associated with High On-Clopidogrel Platelet Reactivity"],"prefix":"10.1007","volume":"14","author":[{"given":"Zuzana","family":"Motovska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Ondrakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Doktorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Widimsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,12]]},"reference":[{"key":"74_CR1","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","volume":"106","author":"DM Lloyd-Jones","year":"2002","unstructured":"Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D\u2019Agostino RB, Kannel WB, for the Framingham Heart Study, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068\u201372.","journal-title":"Circulation"},{"issue":"14","key":"74_CR2","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, from ESC Committee for Practice Guidelines, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787\u2013847.","journal-title":"Eur Heart J"},{"key":"74_CR3","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","volume":"125","author":"VL Roger","year":"2012","unstructured":"Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association. Circulation. 2012;125:e2\u2013220.","journal-title":"Circulation"},{"key":"74_CR4","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1056\/NEJMra021498","volume":"348","author":"M Jessup","year":"2003","unstructured":"Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007\u201318.","journal-title":"N Engl J Med"},{"key":"74_CR5","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/hc3801.097475","volume":"104","author":"SC Smith Jr","year":"2001","unstructured":"Smith SC Jr, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K, et al. AHA\/ACC Scientific Statement: AHA\/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 2001;104:1577\u20139.","journal-title":"Circulation"},{"key":"74_CR6","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/01.CIR.90.6.2645","volume":"90","author":"M Emond","year":"1994","unstructured":"Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR Jr, Chaitman BR, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645\u201357.","journal-title":"Circulation"},{"key":"74_CR7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/hrt.80.5.437","volume":"80","author":"A Michalsen","year":"1998","unstructured":"Michalsen A, K\u00f6nig G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart. 1998;80:437\u201341.","journal-title":"Heart"},{"key":"74_CR8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/euhj.2000.2175","volume":"22","author":"AU Khand","year":"2001","unstructured":"Khand AU, Gemmell I, Rankin AC, Cleland JG. Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges. Eur Heart J. 2001;22:153\u201364.","journal-title":"Eur Heart J"},{"key":"74_CR9","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq172","volume":"31","author":"W Wijns","year":"2010","unstructured":"Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2010;31:2501\u201355.","journal-title":"Eur Heart J"},{"key":"74_CR10","doi-asserted-by":"crossref","unstructured":"Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574\u2013651. doi: 10.1161\/CIR.0b013e31823ba622 .","DOI":"10.1161\/CIR.0b013e31823ba622"},{"key":"74_CR11","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787\u2013847.","journal-title":"Eur Heart J"},{"key":"74_CR12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.amjcard.2011.09.016","volume":"109","author":"GL Sardi","year":"2012","unstructured":"Sardi GL, Gaglia MA Jr, Maluenda G, Torguson R, Laynez-Carnicero A, Ben-Dor I, et al. Outcome of percutaneous coronary intervention utilizing drug-eluting stents in patients with reduced left ventricular ejection fraction. Am J Cardiol. 2012;109:344\u201351.","journal-title":"Am J Cardiol"},{"key":"74_CR13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0002-9149(03)00261-3","volume":"91","author":"PC Keelan","year":"2003","unstructured":"Keelan PC, Johnston JM, Koru-Sengul T, Detre KM, Williams DO, Slater J, et al. Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions\u00a0<\u00a0or\u00a0=\u00a040%, 41% to 49%, and\u00a0>\u00a0or\u00a0=\u00a050% having percutaneous coronary revascularization. Am J Cardiol. 2003;91:1168\u201372.","journal-title":"Am J Cardiol"},{"key":"74_CR14","doi-asserted-by":"crossref","unstructured":"Petr R, Motovska Z, Marinov I, Bilkova D, Widimsky P. Resistance to clopidogrel assessed by VASP phosphorylation is a negative prognostic factor in patients undergoing elective PCI for stable coronary artery disease: analysis from laboratory substudy of PRAGUE 8 trial. J Am Coll Cardiol. 2010;55:A98.E926. doi: 10.1016\/S0735-1097(10)60927-8 .","DOI":"10.1016\/S0735-1097(10)60927-8"},{"key":"74_CR15","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.2011.1332","volume":"306","author":"G Parodi","year":"2011","unstructured":"Parodi G, Marcucci R, Valenti R, et al. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. JAMA. 2011;306:1215\u201323.","journal-title":"JAMA"},{"key":"74_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijcard.2009.01.017","volume":"144","author":"Z Motovska","year":"2010","unstructured":"Motovska Z, Widimsky P, Petr R, Bilkova D, Marinov I, Simek S, et al. Optimal pretreatment timing for high load dosing (600\u00a0mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectivity\u2014the laboratory substudy of the PRAGUE-8 study. Int J Cardiol. 2010;144:255\u20137.","journal-title":"Int J Cardiol"},{"key":"74_CR17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jacc.2009.08.082","volume":"55","author":"A Bellemain-Appaix","year":"2010","unstructured":"Bellemain-Appaix A, Montalescot G, Silvain J, Barth\u00e9l\u00e9my O, Beygui F, Collet JP, ALBION Investigators, et al. Slow response to clopidogrel predicts low response. J Am Coll Cardiol. 2010;55:815\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"74_CR18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","volume":"56","author":"L Bonello","year":"2010","unstructured":"Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, Working Group on High On-Treatment Platelet Reactivity, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010;56:919\u201333.","journal-title":"J Am Coll Cardiol"},{"key":"74_CR19","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Academic Research Consortium, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344\u201351.","journal-title":"Circulation"},{"key":"74_CR20","doi-asserted-by":"crossref","unstructured":"European Perspectives in Cardiology Centres of Excellence: the Cardiocentre Prague, Czech Republic. Circulation. 2008;118(Suppl):f13\u201318.","DOI":"10.1161\/CIRCULATIONAHA.108.191134"},{"issue":"3 Suppl","key":"74_CR21","doi-asserted-by":"crossref","first-page":"20A","DOI":"10.1016\/j.amjcard.2008.11.019","volume":"103","author":"AD Michelson","year":"2009","unstructured":"Michelson AD. Methods for the measurement of platelet function. Am J Cardiol. 2009;103(3 Suppl):20A\u20136A.","journal-title":"Am J Cardiol"},{"key":"74_CR22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1538-7836.2009.03733.x","volume":"8","author":"HJ Bouman","year":"2010","unstructured":"Bouman HJ, Parlak E, van Werkum JW, Breet NJ, ten Cate H, Hackeng CM, et al. Which platelet function test is suitable to monitor clopidogrel responsiveness. J Thromb Haemost. 2010;8:482\u20138.","journal-title":"J Thromb Haemost"},{"key":"74_CR23","doi-asserted-by":"crossref","first-page":"A28","DOI":"10.1093\/eurheartj\/sum081","volume":"10","author":"C Gachet","year":"2008","unstructured":"Gachet C, Aleil B. Testing antiplatelet therapy. Eur Heart J Suppl. 2008;10:A28\u201334.","journal-title":"Eur Heart J Suppl"},{"issue":"suppl G","key":"74_CR24","doi-asserted-by":"crossref","first-page":"G53","DOI":"10.1093\/eurheartj\/sul056","volume":"8","author":"AD Michelson","year":"2006","unstructured":"Michelson AD, Frelinger AL, Furman MI. Resistance to antiplatelet drugs. Eur Heart J Suppl. 2006;8(suppl G):G53\u20138.","journal-title":"Eur Heart J Suppl"},{"key":"74_CR25","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehl275","volume":"27","author":"T Geisler","year":"2006","unstructured":"Geisler T, Langer H, Wydymus M, G\u00f6hring K, Z\u00fcrn C, Bigalke B, et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J. 2006;27:2420\u20135.","journal-title":"Eur Heart J"},{"key":"74_CR26","doi-asserted-by":"crossref","unstructured":"Motovska Z, Knot J, Widimsky P. Stent thrombosis\u2013risk assessment and prevention. Cardiovasc Ther. 2010;28:e92\u2013100. doi: 10.1111\/j.1755-5922.2010.00186.x .","DOI":"10.1111\/j.1755-5922.2010.00186.x"},{"key":"74_CR27","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(08)60422-5","volume":"371","author":"SD Wiviott","year":"2008","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Riesmeyer J, Weerakkody G, et al. TRITON-TIMI 38 trial investigators. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet. 2008;371:1353\u201363.","journal-title":"Lancet"},{"key":"74_CR28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0735-1097(02)01731-X","volume":"39","author":"RE Shaw","year":"2002","unstructured":"Shaw RE, Anderson HV, Brindis RG, Krone RJ, Klein LW, McKay CR, et al. Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998\u20132000. J Am Coll Cardiol. 2002;39:1104\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"74_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MCA.0b013e328351162d","volume":"23","author":"K Silva De","year":"2012","unstructured":"De Silva K, Webb I, Sicard P, Lockie T, Pattinson S, Redwood S, et al. Does left ventricular function continue to influence mortality following contemporary percutaneous coronary intervention? Coronary Artery Dis. 2012;23:155\u201361.","journal-title":"Coronary Artery Dis"},{"key":"74_CR30","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.jacc.2010.02.005","volume":"55","author":"ED Peterson","year":"2010","unstructured":"Peterson ED, Dai D, DeLong ER, Brennan JM, Singh M, Rao SV, on behalf of the NCDR Registry Participants, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010;55:1923\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"74_CR31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1253\/circj.CJ-11-0398","volume":"76","author":"S Tanaka","year":"2012","unstructured":"Tanaka S, Sakata R, Marui A, Furukawa Y, Kita T, Kimura T, CREDO-Kyoto Investigators. Predicting long-term mortality after first coronary revascularization: the Kyoto model. Circ J. 2012;76:328\u201334.","journal-title":"Circ J"},{"key":"74_CR32","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/eurheartj\/ehr034","volume":"32","author":"M Mulder de","year":"2011","unstructured":"de Mulder M, Gitt A, van Domburg R, Hochadel M, Seabra-Gomes R, Serruys PW, et al. EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. Eur Heart J. 2011;32:1398\u2013408.","journal-title":"Eur Heart J"},{"key":"74_CR33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0735-1097(96)00452-4","volume":"29","author":"I Moussa","year":"1997","unstructured":"Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol. 1997;29:6\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"74_CR34","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126\u201330.","journal-title":"JAMA"},{"key":"74_CR35","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","volume":"53","author":"JW Werkum van","year":"2009","unstructured":"van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol. 2009;53:1399\u2013409.","journal-title":"J Am Coll Cardiol"},{"key":"74_CR36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/01.CIR.60.3.497","volume":"60","author":"J Mehta","year":"1979","unstructured":"Mehta J, Mehta P. Platelet function studies in heart disease. VI. Enhanced platelet aggregate formation activity in congestive heart failure: inhibition by sodium nitroprusside. Circulation. 1979;60:497\u2013503.","journal-title":"Circulation"},{"key":"74_CR37","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/eurheartj\/ehl305","volume":"27","author":"I Chung","year":"2006","unstructured":"Chung I, Lip GY. Platelets and heart failure. Eur Heart J. 2006;27:2623\u201331.","journal-title":"Eur Heart J"},{"key":"74_CR38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/dmd.31.1.53","volume":"31","author":"TA Clarke","year":"2003","unstructured":"Clarke TA, Waskell LA. The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin. Drug Metab Dispos. 2003;31:53\u20139.","journal-title":"Drug Metab Dispos"},{"key":"74_CR39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1527-5299.2003.02399.x","volume":"9","author":"DA Sica","year":"2003","unstructured":"Sica DA. Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics. Congest Heart Fail. 2003;9:287\u201392.","journal-title":"Congest Heart Fail"},{"key":"74_CR40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/00912700022008649","volume":"40","author":"SI Sokol","year":"2000","unstructured":"Sokol SI, Cheng A, Frishman WH, Kaza CS. Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure. J Clin Pharmacol. 2000;40:11\u201330.","journal-title":"J Clin Pharmacol"},{"key":"74_CR41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1389200043335577","volume":"5","author":"C Fradette","year":"2004","unstructured":"Fradette C, Du Souich P. Effect of hypoxia on cytochrome P450 activity and expression. Curr Drug Metab. 2004;5:257\u201371.","journal-title":"Curr Drug Metab"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-014-0074-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-014-0074-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-014-0074-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T12:43:48Z","timestamp":1648817028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-014-0074-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,12]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["74"],"URL":"https:\/\/doi.org\/10.1007\/s40256-014-0074-3","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,12]]}}}